Back to list

Huma

Developer of a mobile application designed to improve every facet of digital health through data.
Developer of a mobile application designed to improve every facet of digital health through data.
Other Healthcare Technology Systems 📍 London, United Kingdom Founded 2011
Current Valuation
$1.3B
as of 2024-Q3
UNICORN

QL Price

$1.3B
0% vs last round
QuantLogix's current estimate for Huma, published 2026-09-12 — in line with the last disclosed round of $1.3B (2024-Q3).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round $1.3B 2024-Q3 weight 0.26
How this price has held up
No round has priced for Huma since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-12 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Huma →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Huma, 2026-09-12 (d00b0e92b0f45001). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is Huma going public?
No. Huma is private and has not filed to go public. There is no S-1 on file.
What is Huma's valuation in 2026?
Huma is valued at $1.3B as of 2024-Q3, set by its Series D ($117.94M, Jul 2024). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Huma filed an S-1?
No public S-1 is on file for Huma.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

Founded
2011
HQ
London, United Kingdom
Employees
450
Total Raised
$359.6M
Last Round
Series D — $117.94M (Jul 2024)
IPO Status
private

Fundraising Status

Series D · $117.94M · 2y 2mo ago
privateTotal raised $359.6M

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series D$117.94MJul 2024$1.3B

Talent Signal

Hiring trend
First snapshot
trend accrues with monthly sweeps
Open roles
3
via careers page
Product-build share
67%
engineering, research, product, design
Trajectory
steady
heavy product build — 67% of open roles are product-building functions (engineering/research/product) — 1 of 3 open roles are legal.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by month3Aug '26
Open roles by function
Open roles by functionLegal & Policy1Clinical & Science1Research1
product-building   go-to-market / G&A
Clinical TrialsLife Sciences & Clinical ResearchQuality & Regulatory
Counted from Huma's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health CareInformation TechnologymHealth
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q3. Refreshed quarterly.